235 related articles for article (PubMed ID: 12540064)
1. Treatment of chronic hepatitis B with interferon-alpha: cost-effectiveness in developing countries.
Aggarwal R; Ghoshal UC; Naik SR
Natl Med J India; 2002; 15(6):320-7. PubMed ID: 12540064
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic type B and C hepatitis with interferon alfa: an economic appraisal.
Dusheiko GM; Roberts JA
Hepatology; 1995 Dec; 22(6):1863-73. PubMed ID: 7489999
[TBL] [Abstract][Full Text] [Related]
3. Chronic hepatitis B treatment: the cost-effectiveness of interferon compared to lamivudine.
Almeida AM; da Silva AL; Cherchiglia ML; Andrade EI; de Oliveira GL; Acurcio Fde A
Value Health; 2011; 14(5 Suppl 1):S24-8. PubMed ID: 21839893
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
Babu S
Natl Med J India; 2003; 16(3):175; author reply 175-6. PubMed ID: 12929872
[No Abstract] [Full Text] [Related]
5. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
Desai HG
Natl Med J India; 2003; 16(3):175; author reply 175-6. PubMed ID: 12929870
[No Abstract] [Full Text] [Related]
6. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
Nagral A
Natl Med J India; 2003; 16(3):175; author reply 175-6. PubMed ID: 12929871
[No Abstract] [Full Text] [Related]
7. Economic evaluation of lamivudine compared with interferon-alpha in the treatment of chronic hepatitis B in the United States.
Brooks EA; Lacey LF; Payne SL; Miller DW
Am J Manag Care; 2001 Jul; 7(7):677-82. PubMed ID: 11464426
[TBL] [Abstract][Full Text] [Related]
8. [Cost effectiveness of the treatment of chronic hepatitis C with interferon-alpha].
Buti M; Casado MA; Fosbrook L; Esteban R
Gastroenterol Hepatol; 1998 Apr; 21(4):161-8. PubMed ID: 9633175
[TBL] [Abstract][Full Text] [Related]
9. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective.
Veldhuijzen IK; Toy M; Hahné SJ; De Wit GA; Schalm SW; de Man RA; Richardus JH
Gastroenterology; 2010 Feb; 138(2):522-30. PubMed ID: 19879275
[TBL] [Abstract][Full Text] [Related]
10. Global cost-effectiveness of cataract surgery.
Lansingh VC; Carter MJ; Martens M
Ophthalmology; 2007 Sep; 114(9):1670-8. PubMed ID: 17383730
[TBL] [Abstract][Full Text] [Related]
11. The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C.
Shiell A; Briggs A; Farrell GC
Med J Aust; 1994 Mar; 160(5):268-72. PubMed ID: 8107627
[TBL] [Abstract][Full Text] [Related]
12. What is the cost-effectiveness of hepatitis C treatment for injecting drug users on methadone maintenance in New Zealand?
Sheerin IG; Green FT; Sellman JD
Drug Alcohol Rev; 2004 Sep; 23(3):261-72. PubMed ID: 15370005
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H
J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
[TBL] [Abstract][Full Text] [Related]
14. Is it cost-effective to treat recurrent hepatitis C infection in orthotopic liver transplantation patients?
Saab S; Ly D; Han SB; Lin RK; Rojter SE; Ghobrial RM; Busuttil RW
Liver Transpl; 2002 May; 8(5):449-57. PubMed ID: 12004345
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of group psychotherapy for depression in Uganda.
Siskind D; Baingana F; Kim J
J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
[TBL] [Abstract][Full Text] [Related]
16. Economic consequences of HIV/AIDS in India.
Pandav CS; Anand K; Shamanna BR; Chowdhury S; Nath LM
Natl Med J India; 1997; 10(1):27-30. PubMed ID: 9069706
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia.
Reed SD; Anstrom KJ; Ludmer JA; Glendenning GA; Schulman KA
Cancer; 2004 Dec; 101(11):2574-83. PubMed ID: 15493042
[TBL] [Abstract][Full Text] [Related]
18. [Cost-effectiveness analysis of the treatment of chronic hepatitis C].
Joliot E; Vanlemmens C; Kerleau M; Le Gales C; Woronoff-Lemsi MC; Flori YA; Seror V; Hrusovsky S; Monnet E; Bresson-Hadni S; Miguet JP
Gastroenterol Clin Biol; 1996; 20(11):958-67. PubMed ID: 9119185
[TBL] [Abstract][Full Text] [Related]
19. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
Rothberg MB; Rose DN
Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom.
Bermingham SL; Hughes R; Fenu E; Sawyer LM; Boxall E; T Kennedy P; Dusheiko G; Hill-Cawthorne G; Thomas H
Value Health; 2015 Sep; 18(6):800-9. PubMed ID: 26409607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
